000 | 01231 a2200325 4500 | ||
---|---|---|---|
005 | 20250515112731.0 | ||
264 | 0 | _c20080923 | |
008 | 200809s 0 0 eng d | ||
022 | _a1651-2227 | ||
024 | 7 |
_a10.1111/j.1651-2227.2008.00653.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMehta, Atul | |
245 | 0 | 0 |
_aGaucher disease: unmet treatment needs. _h[electronic resource] |
260 |
_bActa paediatrica (Oslo, Norway : 1992) _cApr 2008 |
||
300 |
_a83-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_a1-Deoxynojirimycin _xanalogs & derivatives |
650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aGaucher Disease _xcomplications |
650 | 0 | 4 |
_aGlucosylceramidase _xtherapeutic use |
650 | 0 | 4 | _aGlycoside Hydrolase Inhibitors |
650 | 0 | 4 | _aHealth Services Accessibility |
650 | 0 | 4 |
_aHematologic Neoplasms _xetiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKnee Joint _xpathology |
650 | 0 | 4 | _aMagnetic Resonance Imaging |
650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
773 | 0 |
_tActa paediatrica (Oslo, Norway : 1992) _gvol. 97 _gno. 457 _gp. 83-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1651-2227.2008.00653.x _zAvailable from publisher's website |
999 |
_c17840913 _d17840913 |